Design of New Antidepressants, 4-Anilinopyrimidine Derivatives, Based on Quantitative Structure-Activity Relationships

Abstract

A quantitative structure-activity relationship formulated for 59 4-anilinopyrimidines inhibiting reserpine-induced ptosis was applied to the design of new, more active, antidepressant compounds. The utility of correlation equations in designing new congeners is discussed and the designed compounds synthesized show the most active group of the anilinopyrimidines.